Literature DB >> 37065

Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.

D G McDevitt.   

Abstract

Mesh：

Substances：

Year:  1979        PMID： 37065     DOI： 10.2165/00003495-197917040-00002

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  111 in total

1.  Alpha sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart.

Authors:  K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

2.  Adrenergic blockade. A new approach to hyperthyroidism during pregnancy.

Authors:  A Langer; C T Hung; J A Mc A'nulty; J T Harrigan; E Washington
Journal:  Obstet Gynecol       Date:  1974-08       Impact factor: 7.661

3.  Electrocardiogram, plasma catecholamines and lipids, and their modification by oxyprenolol when speaking before an audience.

Authors:  P Taggart; M Carruthers; W Somerville
Journal:  Lancet       Date:  1973-08-18       Impact factor: 79.321

4.  Clinical response to long-term propranolol therapy in hyperthyroidism.

Authors:  B Pimstone; B Joffe; N Pimstone; F Bonnici; W P Jackson
Journal:  S Afr Med J       Date:  1969-09-27

5.  Propranolol in patients with angina pectoris.

Authors:  R E Gianelly; R H Goldman; B Treister; D C Harrison
Journal:  Ann Intern Med       Date:  1967-12       Impact factor: 25.391

6.  Clinical pharmacology and therapeutic application of prazosin in acute and chronic refractory congestive heart failure. Balanced systemic venous and arterial dilation improving pulmonary congestion and cardiac output.

Authors:  N A Awan; R R Miller; M P Miller; K Specht; Z Vera; D T Mason
Journal:  Am J Med       Date:  1978-07       Impact factor: 4.965

7.  Effects of thyroid state on adrenoceptor properties.

Authors:  G Kunos; I Vermes-Kunos; M Nickerson
Journal:  Nature       Date:  1974-08-30       Impact factor: 49.962

8.  Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension.

Authors:  J W Hollifield; K Sherman; R V Zwagg; D G Shand
Journal:  N Engl J Med       Date:  1976-07-08       Impact factor: 91.245

Review 9.  Pharmacological effects of labetalol in man.

Authors:  D A Richards
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

10.  Clinical use of I.C.I. 50172 as an antidysrhythmic agent in heart failure.

Authors:  D G Gibson; R Balcon; E Sowton
Journal:  Br Med J       Date:  1968-07-20
View more
  20 in total

1.  Current status of Beta blocker therapy.

Authors:  J D Gray
Journal:  Can Fam Physician       Date:  1980-05       Impact factor: 3.275

2.  Pharmacokinetic-pharmacodynamic modelling of oxprenolol in man using continuous non-invasive blood pressure monitoring.

Authors:  R Koopmans; B Oosterhuis; J M Karemaker; J Wemer; C J van Boxtel
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension.

Authors:  W Schiess; D Welzel; R Gugler
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?

Authors:  D G McDevitt
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

5.  Improved deep controlled hypotension in aneurysmal surgery.

Authors:  V Lüben; G Hempelmann
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

Review 6.  Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update.

Authors:  J G Riddell; D W Harron; R G Shanks
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

7.  Effects of propranolol on conditioned suppression, discriminated punishment and discriminated non-reward in the rat.

Authors:  P Salmon; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

8.  Pharmacological activity of ACC-7513, a selective alpha-adrenoceptor and 5-hydroxytryptamine receptor blocking agent.

Authors:  W G Anderson; S T Kam
Journal:  Br J Pharmacol       Date:  1985-04       Impact factor: 8.739

9.  Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.

Authors:  P C O'Connor; M J Finch; D W Harron; P A Meredith; D G McDevitt; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

10.  Soft drugs. XX. Design, synthesis, and evaluation of ultra-short acting beta-blockers.

Authors:  H S Yang; W M Wu; N Bodor
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.